Novel techniques have been developed to image cells at cellular and subcellular levels. They allow images to be analyzed with ultra-high resolution, in 2D and/or 3D. Several of these tools have been tested on cytology specimens demonstrating emerging applications that are likely to change the field of cytopathology. This review covers several of these advanced imaging methods. The use of optical coherence tomography to perform optical biopsies during endoscopic ultrasound procedures or visualize cells within effusion samples is discussed. The potential for quantitative phase microscopy to accurately screen Pap test slides or resolve indeterminate diagnoses in urine cytology is reviewed. The article also examines the application of 3D cytology using LuCED for lung cancer detection in sputum samples and the feasibility of imaging flow and mass cytometry to measure multiple biomarkers at the single cell level. Although these novel technologies have great potential, further research is necessary to validate their routine use in cytopathology practice.
| I N TR ODU C TI ON
Several novel advanced imaging techniques have been developed that permit digital images to be acquired with high resolution and/or in three dimensions (3D). Some of these microscopic imaging technologies can even provide imaging at a subcellular level. Certain techniques have been coupled with fiber optics, allowing them to be integrated with devices such as endoscopes that permit "optical biopsies" to be obtained inside the body. These imaging modalities have exciting potential in diagnostic pathology and biomedical research. [1] [2] [3] In the last decade, several of these novel technologies have been successfully applied to imaging cytology specimens. Emerging applications in the field of cytopathology such as in vivo screening are therefore anticipated. Hence, it is important that cytologists are aware of this imaging trend, understand these advanced imaging techniques, as well as the potential impact they may have on the field of cytopathology. This article reviews the application of several advanced imaging methods recently applied to cytology such as optical coherence tomography (OCT), 3D tomographic imaging, quantitative phase microscopy (QPM), imaging flow, and mass cytometry.
| OP T IC AL COH E RE NC E T OM OGR AP H Y
Optical coherence tomography (OCT) is analogous to ultrasound imaging, except that it uses light instead of sound. 4 By measuring the echo time delay (detected using a technique called low coherence interferometry) and the intensity of back-reflected light, OCT can reveal tissue microstructure with micron-level resolution and 1-2 mm penetration depth. This is similar to histopathology, but eliminates the need to remove tissue. OCT provides label-free imaging (i.e., avoids the need to use contrast agents). Confocal microscopy has been combined with OCT to produce optical coherence microscopy (OCM), which improves the imaging depth. 5 The optical beam scanned across tissue can generate 2D or 3D images.
Since its development, OCT has been adopted for routine clinical practice in several medical fields including ophthalmology (e.g., to
image the retina) and interventional cardiology (e.g., to image coronary vessels). Numerous ex vivo and in situ studies have reported that OCT is able to readily differentiate normal microstructure from neoplasia in several tissues (e.g., cervix, breast, thyroid, bladder, colon polyps, etc.). [6] [7] [8] [9] High-speed OCT offers a novel method for real-time intraoperative evaluation of surgical margins. Whilst OCT is highly sensitive in identifying preinvasive and invasive cancer of the uterine cervix, 10 it
has not yet replaced the Pap test to screen for cervical neoplasia.
Using fiber optics OCT has been integrated with different imaging devices (e.g., endoscopes, laparoscopes, catheters, needles) to allow imaging inside the body. Such endomicroscopic OCT of hollow organs can be used to detect premalignant lesions (e.g., Barret esophagus), assess depth of tumor invasion, and localize submucosal tumors. OCT instruments may offer an alternative to rapid onsite evaluation (ROSE) when the presence of a cytotechnologist and/or pathologist is not possible. One study explored the role of full-field OCT in gastric, pancreatic, pelvic, and lymph-node specimens from patients undergoing endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA). 12 The authors found that abnormal tissue architecture (e.g., infiltrative pancreatic ductal carcinoma, neuroendocrine neoplasm, granuloma in sarcoidosis) was visible in en-face acquired images. However, lesions at the individual cell level (e.g., isolated gastric signet ring cell carcinoma)
could not be detected.
Another cytology investigation explored the feasibility of OCT for imaging pelvic washing specimens fixed in Cytolyt. 13 These fluid samples were imaged using a commercial OCT instrument ( Figure  F1 1). Not only could cells suspended within fluid be detected with OCT, but also it was possible to identify malignant clusters of tumor cells ( Figure  F2 2).
However, artifacts hampered the ability to acquire good quality images and nuclear detail was lacking. Further work is still necessary to verify the use of OCT devices in order to image body fluids (e.g., pleural effusions, ascites) in vivo for diagnostic use. correction model may need to be applied to minimize the effect of stain-induced variations. 23 Early experiments have shown that the SL-QPM system is better at detecting malignant cells (confirmed at surgery to be malignant) that were morphologically diagnosed as "normal" or "indeterminate" by cytopathologists with a light microscope. In a study of 45 bile duct biopsies SL-QPM-derived nuclear nanomorphology not only distinguished benign and malignant epithelial cells, but was also shown to detect features of malignancy in those cells that appeared normal by light microscopy with a discriminatory accuracy of 0.90. 24 When SL-QPM was combined with routine pathologic evaluation, the sensitivity improved to 88.5% from 65.4% of conventional pathology, while maintaining 100% specificity. Quantitative phase imaging (QPI) technology has also been studied in urine cytology. 26 Using unstained, ThinPrep-prepared urine cytology slides several optical parameters (nuclear/cell dry mass, entropy, nucleus-to-cell mass ratio) were calculated for hundreds of urothelial cells. The nuclear features of imaged cells showed significant differences between patients with benign and malignant diagnoses ( Figure  F8 8).
For patients with indeterminate cytologic diagnoses (i.e., atypical and suspicious for malignancy), the nuclear mass and its entropy were significantly higher for those patients with a follow-up diagnosis of malignancy than those patients without a subsequent follow-up diagnosis of malignancy. Clearly, QPI offers great potential for improving the diagnostic accuracy of urine cytology. 
| Flow mass cytometry
With mass cytometry multiple different proteins or nucleic acids can be detected on single cells simultaneously using antibodies differentially labeled with heavy metals and analyzed by mass cytometry. 34, 35 With this novel approach specific heavy-metal isotopes (rather than fluorophores) are tagged to monoclonal antibodies and then detected with time-of-flight (TOF) mass spectrometry, in an instrument commercially available as the CyTOF. 36 The metal-conjugated antibodies are incubated with target cells by protocols similar to those used for traditional flow cytometry. 37 The cell-antibody combinations are introduced into the instrument by a nebulizer. This fine mist is directed into a laminar flow of argon plasma where it is vaporized, atomized and ionized. Multiplexed marker detection is then carried about by atomic mass spectroscopy.
The instrument measures filtered ion-clouds with a TOF detector.
This results in a data matrix where each row represents a single cell and each column is a signal from the metal representing a unique monoclonal antibody ( Figure  F9 9). With this approach, the co-expression of up to 50 antibodies can be accomplished at the single-cell level with minimal signal overlap. Cells can be both phenotypically and functionally studied. CyTOF has great potential for analytical applications in immunology, hematology, oncology and bioanalytical research (e.g., stem cell development, biomarker discovery). (MIBI) has higher resolution capacity generating 50 nm pixels. 45 In the 
